c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors-Reference-Cited by-同舟云学术

c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors

Published:2009-03 Issue:3 Volume:218 Page:568-574
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J. Cell. Physiol.

Author:

Huang Huei-Mei,Liu Juo-Chuan

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Reference41 articles.

1. The transactivating domain of the c-Jun proto-oncoprotein is required for cotransformation of rat embryo cells;Alani;Mol Cell Biol,1991

2. The chronic myelogenous leukemia-specific p210 protein is the product of the bcr-abl hybrid gene;Ben-Neriah;Science,1986

3. Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis;Branford;Blood,2003

4. Suppression of oncogene-induced transformation by a deletion mutant of c-jun;Brown;Oncogene,1992

5. Inhibition of the Abl protein-tyrosine kinase in vitro and in vivo by a 2-phenylaminopyrimidine derivative;Buchdunger;Cancer Res,1996

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exenatide exerts a neuroprotective effect against diabetic cognitive impairment in rats by inhibiting apoptosis: Role of the JNK/c‑JUN signaling pathway;Molecular Medicine Reports;2022-02-02

2. CD69 partially inhibits apoptosis and erythroid differentiation via CD24, and their knockdown increase imatinib sensitivity in BCR‐ABL‐positive cells;Journal of Cellular Physiology;2018-04-16

3. Biological Effect of Antioxidant Fiber from Common Beans (Phaseolus vulgarisL.);Dietary Fiber Functionality in Food and Nutraceuticals;2016-12-23

4. Role of c-Jun in Tumor Necrosis Factor-alpha Inhibition of Activin A-mediated Erythroid Gene Expression in Erythroleukemia K562 Cells;Journal of Experimental & Clinical Medicine;2014-12

5. Activin A induction of erythroid differentiation sensitizes K562 chronic myeloid leukemia cells to a subtoxic concentration of imatinib;American Journal of Physiology-Cell Physiology;2014-01-01